North America accounted for the largest share of the global human vaccine adjuvants market in 2022, and Asia Pacific is expected to record the highest CAGR during 2022–2030. The US held the largest share of the human vaccine adjuvants market in North America. The US holds a significant share of the human vaccine adjuvants market […]